Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petros C Karakousis

Showing results (1-10 of 158) with videos related to

Pageof 16
Sort By:
The Journal of Infectious Diseases|May 15, 2025
A Pivotal Trial in the Decline of TB SanatoriaPetros C Karakousis, Graham Mooney
The Journal of Infectious Diseases|February 13, 2021
Reply to Lai et alVignesh Chidambaram, Petros C Karakousis
The Journal of Infectious Diseases|October 7, 2024
Respiratory Isolation for Tuberculosis: A Historical PerspectivePetros C Karakousis, Graham Mooney
Microbiology (Reading, England)|April 12, 2014
Differential regulation of the two-component regulatory system senX3-regX3 in Mycobacterium tuberculosisDalin Rifat, Petros C Karakousis
Indian Journal of Medical Microbiology|August 14, 2012
Tuberculosis chemotherapy : present situation, possible solutions, and progress towards a TB-free worldNoton K Dutta, Petros C Karakousis
The Journal of Infectious Diseases|March 26, 2025
When Infection Control Practices and Democracy Collide: Reply to Paladino and RivaOlivia S Kates, Petros C Karakousis
The Journal of Infectious Diseases|December 25, 2019
Reply to Hu et al: Could there be detrimental effects of statin adjunctive TB therapy on immune responses?Noton K Dutta, Petros C Karakousis
Microbiology and Molecular Biology Reviews : MMBR|September 4, 2014
Latent tuberculosis infection: myths, models, and molecular mechanismsNoton K Dutta, Petros C Karakousis
International Journal of Antimicrobial Agents|October 2, 2014
PA-824 is as effective as isoniazid against latent tuberculosis infection in C3HeB/FeJ miceNoton K Dutta, Petros C Karakousis
Clinical & Developmental Immunology|January 15, 2011
Timing of antiretroviral therapy for HIV in the setting of TB treatmentDamani A Piggott, Petros C Karakousis
Pageof 16

Showing results (1-10 of 158) with videos related to

Sort By:
Pageof 16
The Journal of Infectious Diseases|May 15, 2025
A Pivotal Trial in the Decline of TB SanatoriaPetros C Karakousis, Graham Mooney
The Journal of Infectious Diseases|February 13, 2021
Reply to Lai et alVignesh Chidambaram, Petros C Karakousis
The Journal of Infectious Diseases|October 7, 2024
Respiratory Isolation for Tuberculosis: A Historical PerspectivePetros C Karakousis, Graham Mooney
Microbiology (Reading, England)|April 12, 2014
Differential regulation of the two-component regulatory system senX3-regX3 in Mycobacterium tuberculosisDalin Rifat, Petros C Karakousis
Indian Journal of Medical Microbiology|August 14, 2012
Tuberculosis chemotherapy : present situation, possible solutions, and progress towards a TB-free worldNoton K Dutta, Petros C Karakousis
The Journal of Infectious Diseases|March 26, 2025
When Infection Control Practices and Democracy Collide: Reply to Paladino and RivaOlivia S Kates, Petros C Karakousis
The Journal of Infectious Diseases|December 25, 2019
Reply to Hu et al: Could there be detrimental effects of statin adjunctive TB therapy on immune responses?Noton K Dutta, Petros C Karakousis
Microbiology and Molecular Biology Reviews : MMBR|September 4, 2014
Latent tuberculosis infection: myths, models, and molecular mechanismsNoton K Dutta, Petros C Karakousis
International Journal of Antimicrobial Agents|October 2, 2014
PA-824 is as effective as isoniazid against latent tuberculosis infection in C3HeB/FeJ miceNoton K Dutta, Petros C Karakousis
Clinical & Developmental Immunology|January 15, 2011
Timing of antiretroviral therapy for HIV in the setting of TB treatmentDamani A Piggott, Petros C Karakousis
Pageof 16